Society of Interventional Radiology Multisociety Consensus Position Statement on Prostatic Artery Embolization for Treatment of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: From the Society of Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, Société Française de Radiologie, and the British Society of Interventional Radiology: Endorsed by the Asia Pacific Society of Cardiovascular and Interventional Radiology, Canadian Association for Interventional Radiology, Chinese College of Interventionalists, Interventional Radiology Society of Australasia, Japanese Society of Interventional Radiology, and Korean Society of Interventional Radiology

TY - JOUR

T1 - Society of Interventional Radiology Multisociety Consensus Position Statement on Prostatic Artery Embolization for Treatment of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia

T2 - From the Society of Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, Société Française de Radiologie, and the British Society of Interventional Radiology: Endorsed by the Asia Pacific Society of Cardiovascular and Interventional Radiology, Canadian Association for Interventional Radiology, Chinese College of Interventionalists, Interventional Radiology Society of Australasia, Japanese Society of Interventional Radiology, and Korean Society of Interventional Radiology

AU - McWilliams, Justin P.

AU - Bilhim, Tiago A.

AU - Carnevale, Francisco C.

AU - Bhatia, Shivank

AU - Isaacson, Ari J.

AU - Bagla, Sandeep

AU - Sapoval, Marc R.

AU - Golzarian, Jafar

AU - Salem, Riad

AU - McClure, Timothy D.

AU - Kava, Bruce R.

AU - Spies, James B.

AU - Sabharwal, Tarun

AU - McCafferty, Ian

AU - Tam, Alda L.

N1 - Funding Information: J.P.M. receives personal fees from Boston Scientific (Marlborough, Massachusetts) and Merit Medical (South Jordan, Utah). T.A.B. receives personal fees from Philips (Eindhoven, The Netherlands), Merit Medical, Embolx (Sunnyvale, California), and Terumo (Tokyo, Japan). S.Bh. receives grants and personal fees from Merit Medical and Siemens (Munich, Germany) and personal fees from Embolx and Terumo. A.J.I. receives grants and personal fees from BTG International (London, United Kingdom), grants from Medtronic (Dublin, Ireland), and personal fees from Cook (Bloomington, Indiana), Terumo, ABK Biomedical (Halifax, Nova Scotia, Canada), Boston Scientific, and CrannMed (Galway, Ireland). S.Ba. receives grants and personal fees from Medtronic, Terumo, and Boston Scientific and personal fees from Teleflex (Wayne, Pennsylvania). R.S. receives grants and personal fees from BTG International and personal fees from Eisai (Tokyo, Japan), Bristol-Myers Squibb (New York, New York), and Boston Scientific. B.R.K. is a paid speaker for Merit Medical (Los Angeles, California). None of the other authors have identified a conflict of interest.

PY - 2019/5

Y1 - 2019/5

UR - http://www.scopus.com/inward/record.url?scp=85063349553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063349553&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2019.02.013

DO - 10.1016/j.jvir.2019.02.013

M3 - Article

C2 - 30926185

AN - SCOPUS:85063349553

SN - 1051-0443

VL - 30

SP - 627-637.e1

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

IS - 5

ER -